DOI QR코드

DOI QR Code

A Stevens-Johnson syndrome and acute generalized exanthematous pustulosis overlap caused by antibiotics: A case report

항생제로 인한 스티븐스-존슨증후군과 급성 전신성 발진성 농포증이 중첩으로 나타난 1예와 문헌고찰

  • Myung Pyo Kim (Department of Pulmonology, Gangneung Asan Hospital) ;
  • Yeo Un Lee (Department of Pharmaceuticals, Gangneung Asan Hospital) ;
  • Sya Ron Lim (Department of Pathology, Gangneung Asan Hospital) ;
  • Yeong Sang Yoo (Department of Allergy, Gangneung Asan Hospital)
  • 김명표 (강릉아산병원 호흡기내과) ;
  • 이여운 (강릉아산병원 약제과) ;
  • 임샤론 (강릉아산병원 병리과) ;
  • 유영상 (강릉아산병원 알레르기내과)
  • Received : 2023.11.03
  • Accepted : 2024.01.04
  • Published : 2024.10.30

Abstract

Stevens-Johnson syndrome (SJS) and acute generalized exanthematous pustulosis (AGEP) are 2 distinct entities that can overlap within the spectrum of severe cutaneous adverse reaction (SCAR). AGEP is a self-limiting and drug-induced eruption characterized by sudden onset of sterile pustules, erythema, and sometimes fever. SJS, in contrast, is a severe form of SCAR that causes blistering and necrosis of the skin and mucosal membranes, often leading to significant morbidity and mortality. However, there are cases where patients may present with symptoms that overlap between AGEP and SJS, making it challenging to differentiate the 2 conditions. This report describes a 70-year-old male with nontuberculous mycobacterium tenosynovitis in the left hand, coinfected with methicillin-resistant coagulase-negative Staphylococcus and Klebsiella oxytoca. After administration of additional antibiotics, the patient developed fever and erythematous macules with purpuric centers on the trunk and the extremities. Further examination revealed marked leukocytosis and elevated C-reactive protein levels. Skin biopsy histopathology showed subcorneal intraepidermal pustule formation with neutrophil infiltration. The patient's clinical course improved after cessation of the culprit drugs and treatment with a high-dose systemic steroid. This case highlights the rare occurrence of SJS/AGEP overlap and underscores the importance of prompt diagnosis and appropriate management of these SCAR.

Keywords

References

  1. Gerull R, Nelle M, Schaible T. Toxic epidermal necrolysis and Stevens-Johnson syndrome: a review. Crit Care Med 2011;39:1521-32.
  2. Sidoroff A, Halevy S, Bavinck JN, Vaillant L, Roujeau JC. Acute generalized exanthematous pustulosis (AGEP)--a clinical reaction pattern. J Cutan Pathol 2001;28:113-9.
  3. Moreno-Arrones OM, Carrillo-Gijon R, Sendagorta E, Rios-Buceta L. Acute generalized exanthematous pustulosis simulating Stevens-Johnson syndrome/toxic epidermal necrolysis associated with the use of vismodegib. JAAD Case Rep 2018;4:123-5.
  4. Coleman I, Ruiz G, Brahmbhatt S, Ackerman L. Acute generalized exanthematous pustulosis and Stevens-Johnson syndrome overlap due to hydroxychloroquine: a case report. J Med Case Rep 2020;14:210.
  5. Goh TK, Pang SM, Thirumoorthy T, Goh SG. Acute generalised exanthematous pustulosis and toxic epidermal necrolysis induced by carbamazepine. Singapore Med J 2008;49:507-10.
  6. Lateef A, Tan KB, Lau TC. Acute generalized exanthematous pustulosis and toxic epidermal necrolysis induced by hydroxychloroquine. Clin Rheumatol 2009;28:1449-52.
  7. van Hattem S, Beerthuizen GI, Kardaun SH. Severe flucloxacillin-induced acute generalized exanthematous pustulosis (AGEP), with toxic epidermal necrolysis (TEN)-like features: does overlap between AGEP and TEN exist? Clinical report and review of the literature. Br J Dermatol 2014;171:1539-45.
  8. Bellon T. Mechanisms of severe cutaneous adverse reactions: recent advances. Drug Saf 2019;42:973-92.
  9. Charlton OA, Harris V, Phan K, Mewton E, Jackson C, Cooper A. Toxic epidermal necrolysis and Steven-Johnson syndrome: a comprehensive review. Adv Wound Care (New Rochelle) 2020;9:426-39.
  10. Bastuji-Garin S, Fouchard N, Bertocchi M, Roujeau JC, Revuz J, Wolkenstein P. SCORTEN: a severity-of-illness score for toxic epidermal necrolysis. J Invest Dermatol 2000;115:149-53.
  11. Mockenhaupt M, Viboud C, Dunant A, Naldi L, Halevy S, Bouwes Bavinck JN, et al. Stevens-Johnson syndrome and toxic epidermal necrolysis: assessment of medication risks with emphasis on recently marketed drugs. The EuroSCAR-study. J Invest Dermatol 2008;128:35-44.
  12. Sassolas B, Haddad C, Mockenhaupt M, Dunant A, Liss Y, Bork K, et al. ALDEN, an algorithm for assessment of drug causality in Stevens-Johnson Syndrome and toxic epidermal necrolysis: comparison with casecontrol analysis. Clin Pharmacol Ther 2010;88:60-8.
  13. Kim HW, Choi YS, Won JH, Lee JM, Heo JY, Choi JA, et al. Acute generalized exanthematous pustulosis presumed to be caused by acetaminophen. Allergy Asthma Respir Dis 2017;5:52-5.
  14. Hotz C, Valeyrie-Allanore L, Haddad C, Bouvresse S, Ortonne N, Duong TA, et al. Systemic involvement of acute generalized exanthematous pustulosis: a retrospective study on 58 patients. Br J Dermatol 2013;169:1223-32.
  15. Meiss F, Helmbold P, Meykadeh N, Gaber G, Marsch WCh, Fischer M. Overlap of acute generalized exanthematous pustulosis and toxic epidermal necrolysis: response to antitumour necrosis factor-alpha antibody infliximab: report of three cases. J Eur Acad Dermatol Venereol 2007;21:717-9.
  16. Peermohamed S, Haber RM. Acute generalized exanthematous pustulosis simulating toxic epidermal necrolysis: a case report and review of the literature. Arch Dermatol 2011;147:697-701.
  17. Scheinfeld N, Wesson K, Perry P, Weinberg J. Acute generalized exanthematous pustulosis resembling toxic epidermal necrolysis caused by famotidine. Acta Derm Venereol 2003;83:76-7.
  18. Byerly FL, Nelson KC, Granko RP, Morrell DS, Cairns BA. Valdecoxibassociated acute generalized exanthematous pustulosis. Burns 2005;31:383-7.
  19. Kardaun SH. Acute generalized exanthematous pustulosis (AGEP), presenting with toxic epidermal necrolysis-like features, due to morphine: a neglected culprit? Eur J Dermatol 2011;21:427-8.
  20. Worsnop F, Chong H, Ostlere L, Natkunarajah J. Acute generalized exanthematous pustulosis mimicking toxic epidermal necrolysis in patients with psoriasis: a coincidence? Clin Exp Dermatol 2015;40:688-9.